Cetera Investment Advisers
THC icon

Cetera Investment Advisers’s Tenet Healthcare THC Stock Holding History

Cetera Investment Advisers’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.4M Sell
34,199
-8,792
-20% -$1.62M 0.01% 1440
2026
Q1 		$8.11M Sell
42,991
-3,689
-8% -$777K 0.01% 1187
2025
Q4 		$9.28M Buy
46,680
+15,246
+49% +$3.08M 0.01% 1078
2025
Q3 		$6.38M Buy
31,434
+2,510
+9% +$445K 0.01% 1238
2025
Q2 		$5.09M Buy
28,924
+104
+0.4% +$15.7K 0.01% 1177
2025
Q1 		$3.88M Buy
28,820
+7,801
+37% +$1.03M 0.01% 1278
2024
Q4 		$2.65M Sell
21,019
-454
-2% -$67.5K 0.01% 1443
2024
Q3 		$3.57M Buy
21,473
+1,178
+6% +$178K 0.01% 1201
2024
Q2 		$2.7M Buy
20,295
+3,439
+20% +$414K 0.01% 1359
2024
Q1 		$1.77M Buy
+16,856
New +$1.51M ﹤0.01% 1638
2023
Q4 		– Sell
-3,418
Closed -$225K – 2352
2023
Q3 		$225K Buy
3,418
+28
+0.8% +$2.09K ﹤0.01% 1908
2023
Q2 		$276K Buy
+3,390
New +$241K ﹤0.01% 1803
2023
Q1 		– Sell
-6,111
Closed -$298K – 2244
2022
Q4 		$298K Buy
6,111
+253
+4% +$11.7K ﹤0.01% 1668
2022
Q3 		$302K Sell
5,858
-803
-12% -$47.7K 0.01% 1264
2022
Q2 		$350K Buy
+6,661
New +$464K 0.01% 1315

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cetera Investment Advisers's THC Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Tenet Healthcare (THC) stake by 20% in Q2 2026, selling an estimated $1.62M and leaving 34,199 shares worth $6.4M. The position accounts for 0.01% of the portfolio, ranked #1440.

Cetera Investment Advisers first reported a position in THC in Q2 2022 and has held it in 15 quarters since. The position peaked at $9.28M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Cetera Investment Advisers held 34,199 shares of Tenet Healthcare worth $6.4M as of Q2 2026.
  • Cetera Investment Advisers sold 8,792 Tenet Healthcare shares in Q2 2026, an estimated $1.62M.
  • Tenet Healthcare made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1440 holding.
  • Cetera Investment Advisers first reported a position in Tenet Healthcare in Q2 2022 and has held it in 15 quarters since.
  • Cetera Investment Advisers's Tenet Healthcare position peaked at $9.28M in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.